AmberGen is a cutting-edge biotechnology company based in Waltham, MA, specializing in spatial biology imaging solutions. Their flagship product, Miralys Imaging, harnesses the power of mass spectrometry to transform the field of spatial biology, enabling the analysis of small and large molecules in the same sample, co-registering therapeutic and target information, and achieving new levels of multiplexity.
With the ability to scan entire slides and analyze up to 100 biomarkers in a single scan, AmberGen's Miralys Imaging system offers a wide range of applications, accommodating various sample types such as FFPE, fresh frozen, or TMA. Their innovative technology allows researchers to create new multimodal workflows and integrate other imaging modalities, revolutionizing the way spatial biology is studied and understood.
Generated from the website